ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

ABBV AbbVie Inc

162.73
0.09 (0.06%)
Last Updated: 16:09:46
Delayed by 15 minutes
Share Name Share Symbol Market Type
AbbVie Inc NYSE:ABBV NYSE Common Stock
  Price Change % Change Share Price High Price Low Price Open Price Shares Traded Last Trade
  0.09 0.06% 162.73 163.23 161.14 162.73 754,381 16:09:46

Amended Statement of Beneficial Ownership (3/a)

22/05/2020 10:46pm

Edgar (US Regulatory)


FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

FREYMAN THOMAS C
2. Date of Event Requiring Statement (MM/DD/YYYY)
5/8/2020 

3. Issuer Name and Ticker or Trading Symbol

AbbVie Inc. [ABBV]
(Last)        (First)        (Middle)

1 N. WAUKEGAN ROAD
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__X__ Director                          _____ 10% Owner
_____ Officer (give title below)        _____ Other (specify below)
(Street)

NORTH CHICAGO, IL 60064      

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed(MM/DD/YYYY)
5/12/2020 

6. Individual or Joint/Group Filing(Check Applicable Line)

_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock, $0.01 par value 114759 D  
Common Stock, $0.01 par value 4000 (1)I By spouse in trust 
Common Stock, $0.01 par value 1941 (2)I By spouse as trustee for son 
Common Stock, $0.01 par value 1941 (2)I By spouse as trustee for son 

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares

Explanation of Responses:
(1) The reporting person's spouse is the trustee of the trust. The trust is revocable by his spouse. The reporting person disclaims beneficial ownership of these securities.
(2) Shares are held in an irrevocable trust for the benefit of the reporting person's son. The reporting person's spouse is the trustee of the trust. The reporting person disclaims beneficial ownership of these securities.

Remarks:
The purpose of this amendment is to include the shares held in trust for the benefit of the reporting person's sons.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
FREYMAN THOMAS C
1 N. WAUKEGAN ROAD
NORTH CHICAGO, IL 60064
X



Signatures
Steven L. Scrogham, attorney-in-fact for Thomas C. Freyman5/22/2020
**Signature of Reporting PersonDate

1 Year AbbVie Chart

1 Year AbbVie Chart

1 Month AbbVie Chart

1 Month AbbVie Chart

Your Recent History

Delayed Upgrade Clock